|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.617
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.552
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.477
|
Mouse |
|
|
urogenital system development
|
GO:0001655 |
261 |
0.431
|
Mouse |
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.421
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.391
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.374
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.349
|
Mouse |
|
|
blood circulation
|
GO:0008015 |
195 |
0.341
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.324
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.319
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.286
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.284
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.269
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.265
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.265
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.245
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.237
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.237
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.223
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.213
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.213
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.211
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.207
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.205
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.204
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.200
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.191
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.190
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.184
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.182
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.178
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.177
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.175
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.174
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.170
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.164
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.154
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.149
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.146
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.145
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.144
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.142
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.142
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.142
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.142
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.140
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.140
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.139
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.137
|
Mouse |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.136
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.134
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.134
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.130
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.126
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.121
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.121
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.119
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.119
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.117
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.115
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.113
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.111
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.110
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.109
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.109
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.108
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.108
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.105
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.104
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.104
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.102
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.101
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.101
|
|
|
|
columnar cuboidal epithelial cell maturation
|
GO:0002069 |
4 |
0.101
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.101
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.100
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.100
|
Mouse |
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.099
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.099
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.099
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.098
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.097
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.096
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.094
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.094
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.093
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.093
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.091
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.090
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.090
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.089
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.089
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.087
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.084
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.083
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.082
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.082
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.082
|
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.080
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.079
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.079
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.078
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.078
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.076
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.076
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.075
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.074
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.073
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.073
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.073
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.072
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.071
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.071
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.071
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.071
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.070
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.070
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.070
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.070
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.070
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.069
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.069
|
|
|
|
bone marrow development
|
GO:0048539 |
3 |
0.068
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.068
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.067
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.065
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.064
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.064
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.064
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.064
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.064
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.064
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.064
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.064
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.063
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.062
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.062
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.062
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.062
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.062
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.062
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.060
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.059
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.059
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.059
|
|
|
|
cell cell signaling involved in mammary gland development
|
GO:0060764 |
2 |
0.058
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.058
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.057
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.057
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.057
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.056
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.056
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.056
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.056
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.056
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.056
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.056
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.055
|
|
|
|
epithelial mesenchymal signaling involved in prostate gland development
|
GO:0060738 |
2 |
0.055
|
|
|
|
diaphragm development
|
GO:0060539 |
5 |
0.055
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.055
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.055
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.055
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.055
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.054
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.054
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.054
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.054
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.053
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.053
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.053
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.052
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.052
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.052
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.052
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.052
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.052
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.052
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.051
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.051
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.051
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.051
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.050
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.050
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.049
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.048
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.048
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.048
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.048
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.048
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.048
|
|
|
|
cardioblast migration
|
GO:0003260 |
1 |
0.047
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.047
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.047
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.047
|
|
|
|
semaphorin plexin signaling pathway
|
GO:0071526 |
21 |
0.047
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.047
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.047
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.046
|
Mouse |
|
|
mesoderm development
|
GO:0007498 |
100 |
0.046
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.046
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.046
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.046
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.045
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.045
|
|
|
|
mammary gland lobule development
|
GO:0061377 |
22 |
0.045
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.045
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.045
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.045
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.045
|
|
|
|
progesterone secretion
|
GO:0042701 |
1 |
0.044
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.044
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.044
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.044
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.044
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.044
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.043
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.043
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.043
|
|
|
|
respiratory system process
|
GO:0003016 |
25 |
0.043
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.043
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.043
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.043
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.042
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.042
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.042
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.042
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.042
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.041
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.041
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.041
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.041
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.040
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.040
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.040
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.040
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.040
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.040
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.040
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.040
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.040
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.040
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.039
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.039
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.039
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.039
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.039
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.039
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.039
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.039
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.039
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.039
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.039
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.038
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.038
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.038
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.038
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.038
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.038
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.037
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.037
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.037
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.037
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.037
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.037
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.037
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.036
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.036
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.036
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.036
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.036
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.035
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.035
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.035
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.035
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.035
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.035
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.034
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.034
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.034
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.034
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.034
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.034
|
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.033
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.033
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.033
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.033
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.033
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.033
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.033
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.033
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.033
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.033
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.033
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.033
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.033
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.033
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.033
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.033
|
|
|
|
mesenchyme morphogenesis
|
GO:0072132 |
32 |
0.032
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.032
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.032
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.032
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.032
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.032
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.032
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.032
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.032
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.032
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.032
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.032
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.032
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.032
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.031
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.031
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
40 |
0.031
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.031
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.031
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.031
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.031
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.031
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.031
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.031
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.031
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.031
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.031
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.030
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.030
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.030
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.030
|
|
|
|
cell proliferation involved in kidney development
|
GO:0072111 |
14 |
0.030
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.030
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.030
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.030
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.030
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.029
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.029
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.029
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.029
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.029
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.029
|
|
|
|
lung associated mesenchyme development
|
GO:0060484 |
10 |
0.029
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.029
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.029
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.029
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.029
|
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
26 |
0.029
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.028
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.028
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
23 |
0.028
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.028
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.028
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.028
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.028
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.028
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.028
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.028
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.028
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.028
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.028
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.027
|
|
|
|
mesangial cell development
|
GO:0072143 |
4 |
0.027
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.027
|
|
|
|
cellular response to follicle stimulating hormone stimulus
|
GO:0071372 |
1 |
0.027
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.027
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.027
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.027
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.027
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.027
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.027
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.027
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.027
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.027
|
|
|
|
renal capsule morphogenesis
|
GO:0072128 |
1 |
0.027
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.026
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.026
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.026
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.026
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.026
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.026
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.026
|
|
|
|
trachea development
|
GO:0060438 |
18 |
0.026
|
|
|
|
positive regulation of ureteric bud formation
|
GO:0072107 |
3 |
0.026
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.026
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.026
|
|
|
|
endocardial cushion morphogenesis
|
GO:0003203 |
18 |
0.025
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.025
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.025
|
|
|
|
positive regulation of skeletal muscle cell differentiation
|
GO:2001016 |
4 |
0.025
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.025
|
Mouse |
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.025
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.025
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.025
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.025
|
|
|
|
foregut morphogenesis
|
GO:0007440 |
12 |
0.025
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.025
|
|
|
|
cardiac atrium development
|
GO:0003230 |
24 |
0.025
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.025
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.025
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.025
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
24 |
0.025
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.025
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.025
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.024
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.024
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.024
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.024
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.024
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.024
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.024
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.024
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.024
|
|
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.024
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.024
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.024
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.024
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.024
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.024
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.024
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.024
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.024
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.024
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.024
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.023
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.023
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.023
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.023
|
|
|
|
left lung development
|
GO:0060459 |
4 |
0.023
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.023
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.023
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.023
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.023
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.023
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.023
|
|
|
|
primary prostatic bud elongation
|
GO:0060516 |
2 |
0.023
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.023
|
|
|
|
adherens junction assembly
|
GO:0034333 |
22 |
0.023
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.023
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.023
|
|
|
|
wnt signaling pathway involved in kidney development
|
GO:0061289 |
2 |
0.023
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.023
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.023
|
|
|
|
embryonic forelimb morphogenesis
|
GO:0035115 |
32 |
0.023
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.023
|
|
|
|
intestinal epithelial cell maturation
|
GO:0060574 |
2 |
0.023
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.023
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.023
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.022
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.022
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.022
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.022
|
|
|
|
heart formation
|
GO:0060914 |
16 |
0.022
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.022
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.022
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.022
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.022
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.022
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.022
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.022
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.022
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.022
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.022
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.022
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.022
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.022
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.022
|
|
|
|
osteoblast proliferation
|
GO:0033687 |
18 |
0.022
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.022
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.022
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.022
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.022
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.022
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.022
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.022
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.022
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.022
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.022
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.022
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.022
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.021
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.021
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.021
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.021
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.021
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.021
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.021
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.021
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.021
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.021
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.021
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.021
|
|
|
|
kidney mesenchymal cell proliferation
|
GO:0072135 |
2 |
0.021
|
|
|
|
cardiac epithelial to mesenchymal transition
|
GO:0060317 |
18 |
0.021
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.021
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.021
|
|